Skip to main content

Table 3 Univariate and multivariate analysis for evaluation of the associations between tested parameters and short-term complications

From: Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer

Category

Variables

Overall

Severe (grade ≥3)

Univariate

Multivariate

Univariate

Multivariate

OR

(95% CI)

P value

OR

(95% CI)

P value

OR

(95% CI)

P value

OR

(95% CI)

P value

Clinical

Gendera

0.809

(0.408 to 1.606)

0.545

   

0.538

(0.120 to 2.407)

0.417

   

Agea

1.153

(0.698 to 1.904)

0.578

   

3.316

(1.068 to 10.298)

0.038

3.376

(1.074 to 10.614)

0.037

BMI

0.963

(0.887 to 1.044)

0.358

   

1.012

(0.876 to 1.170)

0.869

   

CCIa

1.528

(0.886 to 2.636)

0.128

   

0.891

(0.332 to 2.394)

0.802

   

ECOG

1.028

(0.468 to 2.257)

0.946

   

0.746

(0.205 to 2.714)

0.657

   

Nutritional

Alba

2.780

(1.041 to 7.424)

0.041

3.628

(1.196 to 11.002)

0.023

1.942

(0.247 to 15.237)

0.528

   

Preoperative Hba

1.912

(0.622 to 5.876)

0.258

   

1.221

(0.152 to 9.819)

0.851

   

Cra

0.974

(0.406 to 2.337)

0.952

   

0.488

(0.062 to 3.822)

0.495

   

SMI

0.977

(0.955 to 1.000)

0.045

0.979

(0.954 to 1.004)

0.105

0.951

(0.916 to 0.987)

0.008

0.952

(0.915 to 0.991)

0.017

Tumor specific

AJCCa

1.304

(1.004 to 1.693)

0.047

1.289

(0.986 to 1.685)

0.063

0.861

(0.334 to 2.220)

0.758

   

Grade

1.372

(0.577 to 3.258)

0.474

   

2.157

(0.276 to 16.854)

0.464

   

Surgical specific

Diversiona

0.871

(0.518 to 1.466)

0.604

   

1.054

(0.409 to 2.272)

0.913

   

OT

0.980

(0.760 to 1.263)

0.876

   

0.826

(0.530 to 1.287)

0.397

   
  1. aCategory variables: male patients versus female patients; diversion: orthotopic neobladder versus non-orthotopic neobladder; cut points are indicated as follows: age >70; preoperative Hb female patients <110 g/L or male patients <120 g/L; Alb <35 g/L; creatine (Cr) >110; AJCC >2 or otherwise, CCI > 7.
  2. AJCC American Joint Committee on Cancer, Alb albumin, BMI body mass index, CCI Charlson Comobidity Index, Cr creatine, ECOG Eastern Cooperative Oncology Group, Hb hemoglobin, OT operation time (h), SMI skeletal muscle index.